Sanofi India has announced a major leadership change, with Managing Director Rodolfo Hrosz set to step down at the end of April 2025. The move is part of an internal transition within the Sanofi group.

Leadership Transition Announced

Sanofi India Limited announced on April 9, 2025, that Managing Director Rodolfo Hrosz will step down from his position effective April 30, 2025. The company confirmed this change in a regulatory filing, stating that Hrosz is taking up a new assignment within the Sanofi group.

The board of directors accepted his resignation during a meeting held on April 9, and expressed appreciation for his contributions. Hrosz will also cease to be a key managerial personnel, senior management personnel, and a member of the board committees from the close of business on April 30.

Appointment as Non-Executive Director

Following his resignation as Managing Director, the board has approved Hrosz’s appointment as an additional non-executive director with effect from May 1, 2025, subject to shareholder approval. This move was made based on the recommendation of the Nomination and Remuneration Committee.

Sanofi India said the process to appoint a successor to the role of managing director will be initiated in due course. Details of Hrosz’s new responsibilities within the group were not disclosed.

Sanofi India Share Price Performance

As of the end of trading on April 9, 2025, Sanofi India’s shares closed at ₹6,080.10 on the NSE, reflecting a 1.66% loss. The Deliverable/Traded Quantity stood at 37.76%, and the company’s market capitalisation is ₹14,002.85 crore.

Conclusion

The departure of Rodolfo Hrosz marks a significant change in leadership at Sanofi India. While the company has not yet named a successor, the board’s decision to retain Hrosz as a non-executive director suggests continuity in strategic direction during the transition.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Aurobindo Pharma’s subsidiary, CuraTeQ Biologics, has announced successful clinical trial results for its investigational biosimilar BP16, designed to replicate the bone health medicine denosumab. The drug is intended to treat various bone-related conditions, including osteoporosis and bone complications arising from cancer and its treatments.

The bioequivalence trial involved 204 healthy volunteers from Australia and New Zealand, comparing BP16 with Prolia, the reference denosumab product marketed in the European Union and the United States.

Therapeutic Applications of BP16

BP16 targets and blocks the RANKL protein, which plays a central role in bone tissue breakdown. This mechanism makes the drug useful for treating:

• Osteoporosis in postmenopausal women
• Bone loss from cancer metastasis
• Bone weakening due to cancer therapy

The company sees this biosimilar as a cost-effective alternative to existing denosumab products, potentially improving access for patients worldwide.

Bioequivalence and Clinical Results

Arpitkumar Prajapati, Head of Clinical Sciences at CuraTeQ Biologics, told CNBC TV18: “The results from our study confirmed that BP16 exhibits a PK profile nearly identical to the reference products, achieving key bioequivalence parameters — maximum serum concentration and area under the curve — within the established bioequivalence range of 80–125%.”

He added that: “Additionally, BP16 demonstrated comparable pharmacodynamics, safety, and immunogenicity profiles to both EU and US versions of the reference product. The study, which included 204 subjects from Australia and New Zealand, successfully met all the predefined endpoints.”

Aurobindo Pharma Share Price Performance

As of the end of trading on April 9, 2025, Aurobindo Pharma’s shares closed at ₹1,055.00 on the NSE, registering a 3.83% decline. The Deliverable/Traded Quantity stood at 32.67%, and the company’s market capitalisation was ₹61,274.57 crore.

Conclusion

The trial success of BP16 marks a significant milestone for CuraTeQ Biologics and Aurobindo Pharma in the biologics space. With the study confirming biosimilarity with existing denosumab products, BP16 could soon offer patients a more affordable therapeutic option for treating serious bone-related conditions.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

JSW Energy Limited announced on April 9, 2025, that its wholly owned subsidiary JSW Neo Energy has completed the acquisition of a 4.7 GW renewable energy platform from O2 Power Pooling Pte. Ltd. for an enterprise value of ₹12,468 crore. O2 Power was originally established in 2020 by global investment giants EQT and Temasek.

The deal significantly boosts JSW Energy’s clean energy footprint and marks a major step toward its green energy ambitions. With this acquisition, JSW Energy’s total installed capacity increases to 12,212 MW, of which 6,554 MW (around 54%) is from renewable sources.

Capacity, Scale, and Growth Outlook

As of FY2025, O2 Power has an installed capacity of 1,343 MW. The acquisition includes a 4,696 MW platform, with 2,259 MW expected to be operational by June 2025, contributing an estimated steady-state EBITDA of ₹1,500 crore. The company plans to invest an additional ₹13,500 crore in capex to scale the platform to its full capacity by June 2027, which is projected to generate EBITDA of ₹3,750 crore annually.

The platform consists of:

• 4,100 MW utility-scale renewable projects
• 596 MW commercial and industrial (C&I) capacity
• 3,722 MW already tied up under PPAs
• 974 MW under Letters of Award/Intent pending PPA signings

The diversified portfolio includes:

• 1.8 GW solar
• 0.5 GW wind
• 1.6 GW hybrid
• 0.9 GW firm and dispatchable renewable energy (FDRE)/round-the-clock (RTC) solutions

The projects are spread across seven resource-rich states, largely concentrated in western India, with a blended average tariff of ₹3.37/kWh.

Advisors and Due Diligence

The transaction involved:

• PwC as transaction advisor
• Khaitan & Co and Herbert Smith as legal advisors
• KPMG for financial and tax due diligence
• Wind Guard for technical due diligence

Management Remarks

Sharad Mahendra, Joint Managing Director and CEO of JSW Energy, told CNBC TV18: “This acquisition brings high-quality assets across resource-rich states, along with a management team and employees having a proven track record in planning and execution. This strategic acquisition brings us closer to achieving our 20 GW capacity target significantly before 2030. O2 Power also brings additional connectivity for 900 MW, which will facilitate our future growth. We warmly welcome O2 Power’s experienced management team and employees to the JSW Energy family.”

JSW Energy Share Price Performance

As of the end of trading on April 9, 2025, JSW Energy’s shares closed at ₹482.45 on the NSE, marking a 1.59% loss. The Deliverable/Traded Quantity stood at 44.81%, and the company’s market capitalisation is ₹84,321.09 crore.

Conclusion

The acquisition of O2 Power adds high-quality, contracted assets to JSW Energy’s portfolio, giving the company a significant push towards its 20 GW renewable target. With diversified assets, robust off-take agreements, and strategic grid connectivity, JSW Energy positions itself for sustained clean energy growth in India’s evolving power sector.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

The State Bank of India (SBI) has withdrawn its limited-period Amrit Kalash Fixed Deposit scheme, as reported by CNBC TV18. This special FD offered a 400-day tenure, with interest rates of 7.10% per annum for general customers and 7.60% for senior citizens. Introduced in April 2023, Amrit Kalash quickly gained popularity due to its comparatively higher returns.

The bank confirmed the withdrawal of the scheme via an official notification on its website.

Amrit Vrishti FD Scheme Still Available

Although Amrit Kalash has been discontinued, SBI continues to offer another special deposit — Amrit Vrishti. This scheme has a tenure of 444 days and was launched on July 15, 2024.

As per the latest rates:

• General Public: 7.25% per annum
• Senior Citizens: 7.75% per annum
• Super Senior Citizens (80+): 7.85% per annum

Amrit Vrishti remains open for investment.

Other SBI Special Fixed Deposit Schemes

In addition to Amrit Vrishti, SBI offers the following targeted deposit schemes:

• SBI Patrons:
  Designed exclusively for super senior citizens, this scheme offers 10 basis points higher interest than the regular senior citizen rate across all tenures.
• SBI WeCare:
  A fixed deposit for senior citizens, offering an attractive 7.50% per annum for terms between 5 and 10 years.

SBI’s standard fixed deposit rates, revised as of June 15, 2024, range between:

• 3.50% to 7.00% for the general public
• 4.00% to 7.50% for senior citizens, depending on tenure.

SBI Share Price Performance

As of the close of trading on April 9, 2025, SBI’s shares closed at ₹742.45 on the NSE, reflecting a 3.40% loss for the day. The Deliverable/Traded Quantity stood at 42.47%, and the bank’s market capitalisation is ₹6,62,608.41 crore.

Conclusion

With the withdrawal of the Amrit Kalash FD, SBI continues to adjust its retail deposit offerings in line with market conditions. However, options such as Amrit Vrishti, SBI Patrons, and WeCare continue to provide attractive alternatives for both general and senior citizen investors looking for stable returns.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Mahindra Aerostructures, a subsidiary of Indian automaker Mahindra & Mahindra, has secured a key contract from Airbus Helicopters, a division of French aerospace giant Airbus. The company will manufacture and assemble the main fuselage of the H130 light single-engine helicopter, which will be shipped to Airbus’s European facilities, as reported by the Economic Times.

About the Airbus H130 Helicopter

The H130 is an intermediate, single-engine helicopter primarily used for passenger transport. Known for its spacious cabin and low sound levels, the model is frequently deployed for tourism, corporate, and medical services.

Mahindra’s involvement in this programme further elevates India’s role in the global supply chain for civil aviation and aerospace.

Strategic Expansion in Aerospace Manufacturing

While the financial details of the deal were not disclosed, the agreement marks a significant milestone for Mahindra Aerostructures, which already supplies to major global firms such as Boeing and Dassault Aviation.

This contract strengthens Mahindra’s position as a trusted partner in aerospace manufacturing and assembly, supporting the Make in India and Atmanirbhar Bharat initiatives.

Airbus and India’s Growing Aerospace Role

This announcement follows a January 2024 partnership between Airbus Helicopters and Tata Group, aimed at jointly manufacturing civilian helicopters in India. The new Mahindra deal further highlights India’s increasing participation in the global aerospace value chain.

Mahindra & Mahindra Share Price Performance

As of the end of trading on April 9, 2025, Mahindra & Mahindra shares closed at ₹2,530.50 on the NSE, recording a 0.27% gain. The Deliverable/Traded Quantity was 53.35%, and the company’s market capitalisation stood at ₹3,14,674.97 crore.

Conclusion

The H130 fuselage contract with Airbus Helicopters marks a significant step for Mahindra Aerostructures in the global aerospace sector. As India deepens its partnerships with global aviation leaders, such agreements underscore the country’s expanding capabilities in high-value aerospace manufacturing.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Garden Reach Shipbuilders & Engineers Ltd. announced on April 9, 2025, that it has received a significant order worth ₹489.98 crore from the Geological Survey of India (GSI). The contract includes the design, construction, and delivery of two coastal research vessels, as reported by CNBC TV18.

The project is scheduled for completion within 26 months from the date of contract signing, further expanding Garden Reach Shipbuilders’ footprint in specialised vessel construction.

MoU with SWAN Defence to Boost Commercial Shipbuilding

On April 8, 2025, Garden Reach Shipbuilders signed a Memorandum of Understanding (MoU) with SWAN Defence and Heavy Industries Ltd. to enhance indigenous capabilities in commercial shipbuilding.

The partnership aims to focus on the construction of commercial vessels and offshore structures, targeting both domestic and international clients, and supporting India’s broader maritime objectives.

Agreement with PWD Nagaland for Modular Steel Bridges

In March 2025, Garden Reach Shipbuilders signed its first-ever MoU with a North-Eastern state, the PWD Nagaland, for the supply of 8 sets of Double Lane Modular Steel bridges.

While the financial value of this agreement was not disclosed, the deal marks a strategic milestone in extending Garden Reach Shipbuilders’ infrastructure solutions to the North-East.

Diversification into Research and Infrastructure Projects

These new developments underline Garden Reach Shipbuilders’ ongoing diversification beyond defence shipbuilding, entering sectors like scientific research support and rural infrastructure. The company continues to align its strategy with national initiatives such as Make in India and Atmanirbhar Bharat, leveraging its design and manufacturing capabilities.

Garden Reach Shipbuilders & Engineers Share Price Performance

As of the end of trading on April 9, 2025, Garden Reach Shipbuilders & Engineers’ shares closed at ₹1,568.00 on the NSE, reflecting a 0.14% gain. The Deliverable/Traded Quantity stood at 18.99%, and the company’s market capitalisation was reported at ₹17,961.75 crore.

Conclusion

With a new ₹489.98 crore order from GSI and strategic MoUs in commercial shipbuilding and rural infrastructure, Garden Reach Shipbuilders continues to expand its operational reach across India. These initiatives not only strengthen its order book but also demonstrate its growing role in supporting India’s maritime and developmental priorities.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

The Bombay Stock Exchange (BSE) announced on April 9, 2025, that Quess Corp will be excluded from several major indices due to its ongoing demerger. The company, currently part of the BSE 500, will also exit indices such as BSE Allcap, BSE Smallcap, BSE MidSmallcap, BSE Services, BSE 250 SmallCap, BSE 400 MidSmallCap, BSE 1000, and BSE 1000 Multicap Equal Size Weighted (25%).

The decision comes as part of the implementation of the Composite Scheme of Arrangement involving Quess Corp, Digitide Solutions, and Bluspring Enterprises.

Bajaj Housing Finance to Replace Quess Corp in Key Indices

Following Quess Corp’s exit, Bajaj Housing Finance will be included in the following indices:

• BSE 500
• BSE 250 SmallCap
• BSE 400 MidSmallCap
• BSE 1000
• BSE 1000 Multicap Equal Size Weighted (25%)

The replacement will take effect as per the index methodology in response to Quess Corp’s demerger activity.

Demerger Record Date and Ratio Announced

Quess Corp has fixed April 15, 2025, as the record date for the demerger. This date will determine the eligibility of shareholders entitled to receive shares in the resulting entities.

Under the approved arrangement, shareholders of Quess Corp will receive 1 equity share each of Digitide Solutions and Bluspring Enterprises for every 1 share held in Quess Corp. The resulting companies are expected to begin trading on BSE and NSE within the next 2 months.

Quess Corp Share Price Performance

As of the end of trading on April 9, 2025, Quess Corp’s shares closed at ₹590.00 on the NSE, reflecting a 7.49% decline for the day. The Deliverable/Traded Quantity stood at 55.67%, and the company’s market capitalisation was recorded at ₹8,788.02 crore.

Conclusion

With the demerger process progressing, Quess Corp is set to exit multiple indices, triggering replacement by Bajaj Housing Finance in key BSE indices. Shareholders can expect allocation of shares in the resulting entities based on the announced demerger ratio. The record date of April 15 will be a key milestone in the restructuring process, with trading in new entities expected to begin in the following 2 months.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Vodafone Idea on April 8, 2025, announced the allotment of ₹36,950 crore worth of equity shares to the Government of India, as reported by CNBC TV18. The move marks a significant turning point for the debt-ridden telecom operator as the government now holds a 48.99% stake, becoming its largest shareholder.

The allotment involved the issuance of 3,695 crore equity shares at a face value of ₹10 each. These were issued at par value, as part of the company’s strategic debt-to-equity conversion.

Equity Conversion Under Telecom Relief Package

The equity conversion follows Vodafone Idea’s earlier disclosure on March 30, 2025, aligning with the Reforms and Support Package for the telecom sector introduced in September 2021. The shares were allotted under Section 62(4) of the Companies Act, 2013, based on directions received from the Ministry of Communications.

The Department of Investment and Public Asset Management (DIPAM) will represent the government’s interest in the company. Post-allotment, the company’s total paid-up capital has expanded to ₹1.08 lakh crore, comprising more than 10,834 crore shares.

Impact on Capital Structure

The conversion significantly changes Vodafone Idea’s ownership pattern and capital structure. The government’s entry as the largest shareholder offers substantial relief to the financially strained telco, which has been struggling with high debt and network investment constraints.

While the government has reiterated that it does not intend to interfere in the company’s management, the equity support provides Vodafone Idea with much-needed financial headroom to improve its competitiveness.

Strategic Significance for the Indian Telecom Sector

This move is seen as part of a broader effort to stabilise the Indian telecom market, which has been under stress due to price wars, regulatory liabilities, and high capital expenditure requirements. Vodafone Idea’s financial support through this equity conversion could help the operator continue its 4G expansion, plan 5G rollouts, and reduce operational challenges.

Vodafone Idea Share Price Performance

As of the end of the trading session on April 8, 2025, Vodafone Idea’s shares closed at ₹7.17, down 2.58% on the NSE. The Deliverable/Traded Quantity stood at 26.27%, and the company’s market capitalisation was recorded at ₹51,188.81 crore.

Conclusion

The government’s decision to convert spectrum dues into equity has offered Vodafone Idea a critical financial lifeline. While it alters the ownership structure, it also paves the way for the telco to stabilise and potentially reclaim market relevance. The move reflects a strong policy push to maintain the private telecom market in India, safeguarding long-term competition and consumer interests.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

NTPC Green Energy Limited, a wholly owned subsidiary of NTPC Limited, has partnered with Mahatma Phule Renewable Energy and Infrastructure Technology Limited (MAHAPREIT) to form a new joint venture named NTPC-MAHAPREIT Green Energy Limited. The partnership was officially established on April 8, 2025, as reported by CNBC TV18.

Under this structure, NTPC Green Energy will hold a 74% equity stake, while MAHAPREIT will own the remaining 26%. The Ministry of Power approved the incorporation of this new entity after receiving required clearances from the Department of Investment and Public Asset Management (DIPAM) and NITI Aayog.

NTPC Green Energy has subscribed to 74,000 equity shares at a face value of ₹10 per share as part of the capital arrangement.

Focus on Ultra Mega Renewable Projects

The newly formed company aims to focus on developing, operating, and maintaining Ultra Mega Renewable Energy Power Parks (UMREPPs) and other renewable projects such as solar, wind, and hybrid power systems, with or without energy storage, up to a total capacity of 10 GW.

While the initial focus will be on Maharashtra, the scope of operations may be expanded to other states in the future, depending on project viability and regulatory support.

Strategic Objectives of the Collaboration

The joint venture aims to accelerate India’s transition to clean energy while supporting both state and central government efforts to enhance energy security. It will focus on developing scalable renewable energy infrastructure that prioritizes cost efficiency and long-term sustainability.

By combining NTPC’s technical expertise with MAHAPREIT’s strong regional presence and infrastructure capabilities, the collaboration is set to maximize impact. Together, they plan to drive growth in the clean energy sector through strategic, sustainable initiatives.

Regulatory and Investment Details

The project aligns with India’s broader clean energy goals and comes with full regulatory clearance. NTPC Green Energy’s share subscription reflects its commitment to expanding NTPC’s green portfolio and contributing to the national renewable energy capacity addition targets.

NTPC Green Energy Share Price Performance

As of the end of trading on April 8, 2025, NTPC Green Energy’s shares closed at ₹96.65 on the NSE, marking a 1.93% gain. The Deliverable/Traded Quantity stood at 37.93%, and the company’s current market capitalisation is ₹81,440.48 crore.

Conclusion

The formation of NTPC-MAHAPREIT Green Energy Limited marks a significant milestone in NTPC’s clean energy journey. With a targeted capacity of 10 GW, this joint venture reinforces India’s renewable energy ambitions while paving the way for large-scale sustainable infrastructure development across multiple states.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

 

SpiceJet’s shares, which surged above ₹60 apiece in October 2024 following a successful ₹3,000 crore Qualified Institutional Placement (QIP), have since fallen over 30% in the past six months. The early optimism surrounding the airline’s financial revival has been dampened by a series of operational and market setbacks.

Flight Reductions Highlight Operational Strain

As reported by CNBC TV18, the airline has scaled back significantly in its latest summer schedule. Compared to the previous winter schedule, 57 flights have been cut. Even more telling, SpiceJet’s summer 2025 weekly schedule is down by 417 flights year-on-year, reflecting reduced capacity and persistent challenges in operations.

Despite the airline claiming 24 aircraft in active service, Planespotter.com data indicates that only 22 planes are currently flying. In January 2025, SpiceJet reported 28 aircraft in operation, with plans to unground 10 additional planes by mid-April. However, instead of expanding, the operational fleet has shrunk.

Fleet Revival Faces Delays

The airline attributes the delay in restoring grounded aircraft to global supply chain disruptions. A SpiceJet spokesperson told CNBC-TV18, “While there have been some delays due to global supply chain constraints, we are working closely with our partners to resolve these bottlenecks and accelerate the return of additional aircraft to service.”

As of now, SpiceJet has managed to revive only three planes—one Boeing 737 MAX, one Boeing 737 NG, and one Q400. Simultaneously, the airline returned five aircraft previously taken on high-cost wet leases.

“Five high-cost wet-leased aircraft have been returned. This move is in line with our strategy to optimise costs and improve the bottom line,” SpiceJet said.

Use of QIP Funds and Future Plans

SpiceJet has utilised approximately ₹2,400 crore of the ₹3,000 crore raised via QIP. Of this, ₹1,500 crore was used to clear statutory payments, vendor dues, employee salaries, and airport-related obligations. The airline had allocated ₹410 crore specifically for reviving grounded aircraft, with ₹170 crore spent during Q3 FY25.

To expedite aircraft revival, the airline has sent several MAX engines to a US-based maintenance firm, Standard Aero Inc., for servicing. SpiceJet is also coordinating with various original equipment manufacturers (OEMs) and MRO partners to bring additional aircraft back into operation.

Conclusion

SpiceJet’s efforts to stabilise operations through fresh funding have yet to yield the expected turnaround. With a shrinking fleet and flight schedule, coupled with limited progress on aircraft revival, the airline faces mounting pressure. While collaboration with MROs and OEMs is ongoing, the coming months will be critical in determining how effectively SpiceJet can navigate its challenges and restore investor confidence.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.